Inverse Relation Between the tumor Necrosis Factor Promoter Methylation and Trascript Leveles in Leukocytes From Patients with Rheumatoid Arthritis.

被引:0
|
作者
Maxwell, James R.
Taylor, Lyndsey H.
Pachecho, Richardo A.
Lawrence, Neil
Duff, Gordon W. [2 ]
Teare, M. Dawn
Wilson, Anthony G. [1 ]
机构
[1] Univ Sheffield, Sect Musculoskeletal Sci, Sheffield, S Yorkshire, England
[2] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England
来源
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
985
引用
收藏
页码:S427 / S427
页数:1
相关论文
共 50 条
  • [41] ASSOCIATION BETWEEN RHEUMATOID FACTOR STATUS AND DISCONTINUATION OF TUMOR NECROSIS FACTOR INHIBITORS DUE TO INEFFECTIVENESS IN RHEUMATOID ARTHRITIS
    Ogawa, Yoshikazu
    Takahashi, Nobunori
    Kojima, Toshihisa
    Ishiguro, Naoki
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 722 - 723
  • [42] Potentiated Antibodies to Tumor Necrosis Factor-α in the Therapy of Patients with Rheumatoid Arthritis
    L. V. Kozlovskaya
    N. A. Mukhin
    V. V. Rameev
    I. A. Sarkisova
    O. I. Epstein
    [J]. Bulletin of Experimental Biology and Medicine, 2003, 135 (Suppl 7) : 152 - 154
  • [43] Predictors of tumor necrosis factor inhibitors primary failure in rheumatoid arthritis patients
    Khafagi, Amira Mohamed
    Mosa, Doaa Mosad
    Hawaas, Salah
    Hafez, Eman Abdelrazek
    [J]. EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2024, 51 (01)
  • [44] Tumor necrosis factor-α antagonist use and cancer in patients with rheumatoid arthritis
    Setoguchi, Soko
    Solomon, Daniel H.
    Weinblatt, Michael E.
    Katz, Jeffrey N.
    Avorn, Jerry
    Glynn, Robert J.
    Francis Cook, E.
    Carney, Greg
    Schneeweiss, Sebastian
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S19 - S19
  • [45] Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
    Emery, Paul
    Vlahos, Bonnie
    Szczypa, Piotr
    Thakur, Mazhar
    Jones, Heather E.
    Woolcott, John
    Estrella, Paul V. Santos
    Rolland, Catherine
    Gibofsky, Allan
    Citera, Gustavo
    Sockalingam, Sargunan
    Marshall, Lisa
    [J]. JOURNAL OF RHEUMATOLOGY, 2020, 47 (04) : 493 - 501
  • [46] Autoantibodies to Tumor Necrosis Factor in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus
    Rosenau, Barbara J.
    Schur, Peter H.
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (04) : 753 - 756
  • [47] Lack of association between promoter polymorphism of the tumor necrosis factor-α gene and psoriatic arthritis in Japanese patients
    Hamamoto, Y
    Tateno, H
    Ishida, T
    Muto, M
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (06) : 1162 - 1163
  • [48] Tumor necrosis factor α-308 and -238 polymorphisms in rheumatoid arthritis.: Association with messenger RNA expression and sTNF-α
    Oregon-Romero, Edith
    Vazquez-Del Mercado, Monica
    Luz Ruiz-Quezada, Sandra
    Elena Navarro-Hernandez, Rosa
    Rangel-Villalobos, Hector
    Martinez-Bonilla, Gloria
    Guilaisne Bernard-Medina, Ana
    Armendariz-Borunda, Juan
    Garcia-Banuelos, Jesus
    Francisco Munoz-Valle, Jose
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (07) : 937 - 943
  • [49] Polymorphism in the tumor necrosis factor-α gene promoter is associated with severity of rheumatoid arthritis in the Czech population
    Nemec, Petr
    Pavkova-Goldbergova, Monika
    Stouracova, Martina
    Vasku, Anna
    Soucek, Miroslav
    Gatterova, Jindra
    [J]. CLINICAL RHEUMATOLOGY, 2008, 27 (01) : 59 - 65
  • [50] Tumor necrosis factor-α promoter-308 A/G polymorphism and rheumatoid arthritis susceptibility:: A metaanalysis
    Lee, Young Ho
    Ji, Jong Dae
    Song, Gwan Gyu
    [J]. JOURNAL OF RHEUMATOLOGY, 2007, 34 (01) : 43 - 49